These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1764379)

  • 1. Verification of the cause of death in the trial of early detection of breast cancer. UK Trial of Early Detection of Breast Cancer Group. Trial Co-ordinating Centre.
    Chamberlain J; Coleman D; Ellman R; Moss S
    Br J Cancer; 1991 Dec; 64(6):1151-6. PubMed ID: 1764379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer.
    Lancet; 1999 Jun; 353(9168):1909-14. PubMed ID: 10371568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with breast cancer diagnosed in the United Kingdom trial of early detection of breast cancer. United Kingdom Trial of Early Detection of Breast Cancer Group.
    Moss SM; Ellman R; Coleman D; Chamberlain J
    J Med Screen; 1994 Jul; 1(3):193-8. PubMed ID: 8790516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer.
    Moss SM; Summerley ME; Thomas BT; Ellman R; Chamberlain JO
    J Epidemiol Community Health; 1992 Aug; 46(4):362-4. PubMed ID: 1431707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misclassification of breast cancer as cause of death in a service screening area.
    Goldoni CA; Bonora K; Ciatto S; Giovannetti L; Patriarca S; Sapino A; Sarti S; Puliti D; Paci E;
    Cancer Causes Control; 2009 Jul; 20(5):533-8. PubMed ID: 19015942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening.
    Autier P; Boniol M; Smans M; Sullivan R; Boyle P
    PLoS One; 2016; 11(4):e0154113. PubMed ID: 27100174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
    Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
    J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gothenburg Breast Screening Trial.
    Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
    Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First results on mortality reduction in the UK Trial of Early Detection of Breast Cancer. UK Trial of Early Detection of Breast Cancer Group.
    Lancet; 1988 Aug; 2(8608):411-6. PubMed ID: 2900351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of early detection of breast cancer: description of method.
    Br J Cancer; 1981 Nov; 44(5):618-27. PubMed ID: 7032568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer as cause of death--a study over the validity of the officially registered cause of death in 2631 breast cancer patients dying in Malmö, Sweden 1964-1992.
    Garne JP; Aspegren K; Balldin G
    Acta Oncol; 1996; 35(6):671-5. PubMed ID: 8938212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of certified causes of death in breast carcinoma patients.
    Rutqvist LE
    Acta Radiol Oncol; 1985; 24(5):385-90. PubMed ID: 3002134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the impact of changes in sensitivity on the outcomes of the UK breast screening programme.
    Taylor P
    J Med Screen; 2010; 17(1):31-6. PubMed ID: 20356943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening in young women.
    Desreux JAC
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():208-211. PubMed ID: 29804884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and harms of breast cancer screening with mammography in women aged 40-49 years: A systematic review.
    van den Ende C; Oordt-Speets AM; Vroling H; van Agt HME
    Int J Cancer; 2017 Oct; 141(7):1295-1306. PubMed ID: 28542784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.